Nurx Stock

nurx.comHealthcare / Healthcare providers & servicesFounded: 2015Funding to Date: $90.87MM

Nurx is a healthcare technology offering primary care solutions including birth control, HPV testing, PrEP for HIV prevention, and STI testing and treatment.

Register To Buy and Sell Shares

For more details on financing and valuation for Nurx, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Nurx’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Nurx.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Edvard Engesaeth MD
Innovation Officer and Co-Founder
Sheena Deol
Executive Assistant
Ted Kraus
Advisor
Jonathan Czaja
Chief Operating Officer
Matthew Dzaman
Head, Engineering
Varsha Rao
Chief Executive Officer
Hans Gangeskar
Co-Founder & Board Member
Michael Hourie
Head of Finance

Board Members

Noah Knauf
Kleiner Perkins
Hans Gangeskar
Chelsea Clinton Ph.D
Clinton Foundation
Regina Benjamin MD

Other companies like Nurx in the Healthcare providers & services sector

Sector
Last Round Est. Valuation
$12.71B
Sector
Last Round Est. Valuation
$648.94MM
Sector
Last Round Est. Valuation
$2.18B
Sector
Last Round Est. Valuation
$1.65B
Sector
Last Round Est. Valuation
$1.53B
Sector
Last Round Est. Valuation
$4.6B
Sector
Last Round Est. Valuation
$10.41MM
Sector
Last Round Est. Valuation
$394.31MM
Sector
Last Round Est. Valuation
$5.7B

News Highlights

Telehealth Startup Nurx Raises $22.5M Series C Extension
Nurx expects to be profitable by early next year.
Healthcare startups Nurx and Carbon Health ship at-home COVID-19 test sample kits – TechCrunch
Efforts to get at-home test kits for the COVID-19 coronavirus are ramping up quickly, and two more health industry startups are bringing their own products to market, with both Carbon Health and Nurx starting to ship their own in-home sample collection kits. Both of these new offerings are the same…
Nurx Receives $52 Million For Expanding Access To Sensitive Health Needs
Nurx, a health tech company that is providing convenient and affordable care for sensitive needs, announced it raised $52 million.
Updated on: Oct 4, 2023

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.